TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ORKA

Oruka Therapeutics, Inc.

Healthcare · Biotechnology

97.70$ +4.5% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Oruka Therapeutics, Inc. (ORKA): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/11/2026.

Next report 11/11/2026
Last report 08/10/2026
Earnings surprise by quarter (%)
Q3 24 · -356.3 % 24 Q4 24 · -31.7 % 24 Q1 25 · 9.1 % 25 Q2 25 · -7.0 % 25 Q3 25 · -5.8 % 25 Q4 25 · 26.9 % 25 Q1 26 · 11.1 % 26 Q2 26 · -12.2 % 26

EPS estimate beaten

Full history 15 of 23 quarters (65%)
Last 16 quarters 11 of 16 quarters (69%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/24/2026 Oruka Therapeutics, Inc. (ORKA): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/10/2026 Oruka Therapeutics, Inc. (ORKA): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?